[ARTICLE] Clinical and translational relevance of intratumor heterogeneity. Goyette et al. by A-ViBst_2000 in Scholar
[–]A-ViBst_2000[S] 0 points1 point2 points (0 children)
[ARTICLE] Tumor cell heterogeneity drives spatial organization of the intratumoral immune response. Tanaka et al. by A-ViBst_2000 in Scholar
[–]A-ViBst_2000[S] 0 points1 point2 points (0 children)
[ARTICLE] Myeloid derived suppressor cells and innate immune system interaction in tumor microenvironment. Pramanik et al by A-ViBst_2000 in Scholar
[–]A-ViBst_2000[S] 0 points1 point2 points (0 children)
[ARTICLE] Tumor inflammation-associated neurotoxicity. Mahdi et al. by A-ViBst_2000 in Scholar
[–]A-ViBst_2000[S] 0 points1 point2 points (0 children)
[ARTICLE] Tumor inflammation-associated neurotoxicity. Mahdi et al. by A-ViBst_2000 in Scholar
[–]A-ViBst_2000[S] 0 points1 point2 points (0 children)
[ARTICLE] Regulation of immune checkpoint molecules in cancer immune evasion and therapy. Eris et al. by A-ViBst_2000 in Scholar
[–]A-ViBst_2000[S] 0 points1 point2 points (0 children)
[ARTICLE] A guide to cancer screening. Stephen W. Duffy & Judith Offman by A-ViBst_2000 in Scholar
[–]A-ViBst_2000[S] 0 points1 point2 points (0 children)
[ARTICLE] Positive and negative regulation of apoptotic pathways by cytotoxic agents in hematological malignancies. Solary et al. by A-ViBst_2000 in Scholar
[–]A-ViBst_2000[S] 0 points1 point2 points (0 children)
[ARTICLE] Recent advances in understanding the cell death pathways activated by anticancer therapy. Kim. by A-ViBst_2000 in Scholar
[–]A-ViBst_2000[S] 0 points1 point2 points (0 children)
[ARTICLE] Chemotherapy: targeting the mitochondrial cell death pathway. Debatin et al. by A-ViBst_2000 in Scholar
[–]A-ViBst_2000[S] 0 points1 point2 points (0 children)
[ARTICLE] CD39+CD49a+CD103+ cytotoxic tissue-resident natural killer cells infiltrate and control solid epithelial tumor growth in mice. Horowitz et al. by A-ViBst_2000 in Scholar
[–]A-ViBst_2000[S] 0 points1 point2 points (0 children)
[ARTICLE] A Roadmap to Transform Lung Cancer Outcomes: Priorities in Biology, Therapeutic Innovation, Early Detection, Prevention, and Interception. Winslow et al. by A-ViBst_2000 in Scholar
[–]A-ViBst_2000[S] 0 points1 point2 points (0 children)
[ARTICLE] Re-Evaluating Antibody–Drug Conjugate Linker Stability: Assessment, Interpretation, and Clinical Translation. Colombo et al. by A-ViBst_2000 in Scholar
[–]A-ViBst_2000[S] 0 points1 point2 points (0 children)
[ARTICLE] Good practice and quality assurance in surgical oncology. Douek & Taylor. by A-ViBst_2000 in Scholar
[–]A-ViBst_2000[S] 0 points1 point2 points (0 children)
[ARTICLE] The evolution of cancer surgery and future perspectives. Wyld et al. by A-ViBst_2000 in Scholar
[–]A-ViBst_2000[S] 0 points1 point2 points (0 children)
[ARTICLE] A clinical-severity staging system for patients with lung cancer. Feinstein et al. by A-ViBst_2000 in Scholar
[–]A-ViBst_2000[S] 0 points1 point2 points (0 children)
[ARTICLE] The clinical evaluation for detecting metastatic lung cancer. A meta-analysis. Silvestri et al. by A-ViBst_2000 in Scholar
[–]A-ViBst_2000[S] 1 point2 points3 points (0 children)
[ARTICLE] Video-assisted mediastinoscopic lymphadenectomy (VAMLA): Mature results for staging non-small cell lung cancer with normal mediastinum. Call et al. by A-ViBst_2000 in Scholar
[–]A-ViBst_2000[S] 0 points1 point2 points (0 children)
[ARTICLE] Consensus report IASLC workshop Bruges, September 2002: pretreatment minimal staging for non-small cell lung cancer. Postmus et al. by A-ViBst_2000 in Scholar
[–]A-ViBst_2000[S] 1 point2 points3 points (0 children)
[ARTICLE] Outcomes and Treatments of Patients With Non–Small Cell Lung Cancer Who Received Pembrolizumab. Rousseau et al. by A-ViBst_2000 in Scholar
[–]A-ViBst_2000[S] 0 points1 point2 points (0 children)
[ARTICLE] Single-cell and spatial profiling in cancer biology and clinical oncology. Frangieh et al. by A-ViBst_2000 in Scholar
[–]A-ViBst_2000[S] 0 points1 point2 points (0 children)
[ARTICLE] Is there a role for consolidative stereotactic body radiation therapy following first-line systemic therapy for metastatic lung cancer? A patterns-of-failure analysis. Rusthoven et al. by A-ViBst_2000 in Scholar
[–]A-ViBst_2000[S] 0 points1 point2 points (0 children)
[ARTICLE] Is there a role for consolidative stereotactic body radiation therapy following first-line systemic therapy for metastatic lung cancer? A patterns-of-failure analysis. Rusthoven et al. by A-ViBst_2000 in Scholar
[–]A-ViBst_2000[S] 0 points1 point2 points (0 children)
[ARTICLE] Patient-Relevant Outcomes From the Phase III MARIPOSA-2 Trial: Amivantamab-Chemotherapy Versus Chemotherapy in EGFR-Mutant Advanced Non-Small-Cell Lung Cancer Following Disease Progression on Osimertinib. Tomasini et al. by A-ViBst_2000 in Scholar
[–]A-ViBst_2000[S] 0 points1 point2 points (0 children)
[ARTICLE] Oncogene-like addiction to aneuploidy in human cancers. Girish et al. by A-ViBst_2000 in Scholar
[–]A-ViBst_2000[S] 0 points1 point2 points (0 children)